Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 13:1:62-66.
doi: 10.1016/j.cnp.2016.09.003. eCollection 2016.

Potential risks of iatrogenic complications of nerve conduction studies (NCS) and electromyography (EMG)

A Gechev  1 , N M Kane  2 , M Koltzenburg  3 , D G Rao  4 , R van der Star  5
Affiliations
Review

Potential risks of iatrogenic complications of nerve conduction studies (NCS) and electromyography (EMG)

A Gechev et al. Clin Neurophysiol Pract. .

Abstract

Nerve conduction and electromyography studies are generally well tolerated and pose little risk to patients of serious adverse events in the hands of a well-trained competent practitioner. However, some patients and certain examinations do carry a higher risk of potential complications. It is good medical practice to inform patients of any risks, their potential severity and relative frequency. In order to obtain informed consent a dialogue should take place about the nature, purpose and effects of the studies, so patients can decide if they wish to undergo the proposed investigation. In this educational review we identify those procedures and patients at risk, and provide pragmatic practice recommendations for managing these material risks.

Keywords: Adverse events; Electromyography; Nerve conduction studies; Recommendations; Risks; Severity.

PubMed Disclaimer

References

    1. American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Risks of Electrodiagnostic Medicine. July 2014; 1–8. <https://www.aanem.org/getmedia/653e87b3-f930-4951-9bd8-dde95c291ce2/risk...>.
    1. Airaksinen K.E.J., Koreila P., Lund J., Ylitalo A., Karjalainen P., Virtanen V., Raatikainen P., Koivisto U.M., Koistinen J. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment – The FinPAC study. Int. J. Cardiol. 2013;168:3679–3682. - PubMed
    1. Almeida H.F., Buckingham T.A. Inappropriate implantable cardioverter defibrillator shocks secondary to sensing lead failure: utility of stored electrograms. Pacing Clin. Electrophysiol. 1993;16:407–411. - PubMed
    1. Al-Shekhlee A., Shapiro B.E., Preston D.C. Iatrogenic complications and risks of nerve conduction studies and needle electromyography. Muscle Nerve. 2003;27:517–526. - PubMed
    1. Armstrong M.J., Gronseth G., Anderson D.C., Biller J., Cucchiara B., Dafer R., Goldstein L., Schneck M., Messé S.R. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80:2065–2069. - PMC - PubMed

LinkOut - more resources